Filing Details
- Accession Number:
- 0001493152-19-009422
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-19 12:17:52
- Reporting Period:
- 2019-06-19
- Accepted Time:
- 2019-06-19 12:17:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
764195 | Vbi Vaccines Inc | VBIV | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1615941 | Jeff Baxter | C/O Vbi Vaccines Inc., 222 Third Street, Ste 2241 Cambridge MA 02142 | Ceo, President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares, No Par Value Per Share | Acquisiton | 2019-06-19 | 144,000 | $0.73 | 458,255 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents the weighted average price of shares purchased in multiple transactions at prices ranging from $0.7199 to $0.748, inclusive. The reporting person undertakes to provide to VBI Vaccines Inc., any security holder of VBI Vaccines Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.